Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 3:58 pm Purchase | 13G | CNS PHARMACEUTICALS INC C CNSP | ARMISTICE CAPITAL LLC | 1,062,287 3.200% | 1,062,287 (New Position) | View |
| 2024-08-02 4:11 pm Purchase | 13D | CNS PHARMACEUTICALS INC C CNSP | Cortice Biosciences Inc. | 573,368 5.700% | 573,368 (New Position) | View |
| 2024-07-02 12:34 pm Unchanged | 13G | CNS PHARMACEUTICALS INC C CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | View |
| 2024-06-25 7:19 pm Unchanged | 13G | CNS PHARMACEUTICALS INC C CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | View |
| 2024-02-14 2:25 pm Purchase | 13G | CNS PHARMACEUTICALS INC C CNSP | ARMISTICE CAPITAL LLC | 676,203 9.990% | 510,747 (+308.69%) | View |
| 2023-08-01 5:07 pm Purchase | 13G | CNS PHARMACEUTICALS INC C CNSP | Priebe Waldemar | 6,667 0.300% | 6,667 (New Position) | View |
| 2023-02-14 12:23 pm Purchase | 13G | CNS PHARMACEUTICALS INC C CNSP | ARMISTICE CAPITAL LLC | 165,456 9.990% | 165,456 (New Position) | View |